S. Kurmani, I. Squire
2017.8.7Current Heart Failure Reports
tlooto Summary
It is suggested that there is significant patient heterogeneity and that AHF is not a single pathology, but rather a range of pathophysiological entities which poses a challenge when designing clinical trials and may explain why the results in this area have been largely disappointing.
Abstract
Purpose of ReviewThe purpose of this review is to describe the extent and scope of acute heart failure (AHF), place it within its clinical context and highlight some of the difficulties in defining it as a pathophysiological entity.Recent FindingsA diagnosis of AHF is made when patients present acutely with signs and symptoms of heart failure, often with decompensation of pre-existing cardiomyopathy. The most current guidelines classify based on clinical features at initial presentation and are used to both risk stratify and guide the management of haemodynamic compromise. Despite this, AHF remains a diagnosis with a poor prognosis and there is no therapy proven to have long-term mortality benefits.SummaryWe provide an introduction to AHF and discuss its definition, causes and precipitants. We also present epidemiological and demographic data to suggest that there is significant patient heterogeneity and that AHF is not a single pathology, but rather a range of pathophysiological entities. This poses a challenge when designing clinical trials and may, at least in part, explain why the results in this area have been largely disappointing.
Citation format
KURMANI, S.; SQUIRE, I. Acute heart failure: Definition, classification and epidemiology. Current Heart Failure Reports, 2017, 14: 385–392.